🔥Hot off the press🔥 🆕Our Comments on various GC protocols in @IJRheum The changing paradigm of glucocorticoid therapy in antineutrophil cytoplasmic antibody-associated vasculitis https://t.co/4BjfkvPVAY https://t.co/gMXg7qQJWY

do we need another IL17a inhibitor? https://t.co/yf8cFNruzU

"Implementation (of guidelines) is key but remains the weakest part of the process" Dr. @DanielAletaha #EULAR2022 @RheumNow https://t.co/9ULIAA7dvg

Easy clinical tool for predicting lymphoma development at the time of #Sjogrens syndrome #EULAR2022 https://t.co/tQ6B0iVRnb

Dr Buch. ORAL Surveillance. MACE, VTE, Malignancy all more common in those with high (>20%) baseline CV risk or history CAD. HRs 1-2 for most but for VTE and high baseline CV risk, HR 6-11! @RheumNow #EULAR2022 POS0237 https://t.co/9DI4KotyOp

Dr Elena Nikiphorou explaining how the Western diet can bring on and worsen inflammation joint disease symptoms. We should look to include more Omega 3 than Omega 6 in our diets #EULAR2022 PB https://t.co/nIKOSDPURU

A very comprehensive overview of progress in the understanding of #IIM pathogenetic mechanisms outlining the role of 👉 Type 1 INF pathway 👉 Vasculopathy 👉 NETs 👉 Mitochondrial Dysfunction #EULAR2022 Dr. Lisa Rider https://t.co/BXbXlYTHYM

Robert Landewe isn't lying down. "I am chatting to my artificial intelligence doctor in the United States. I am asking him why I had a headache in the last talk" He worries telehealth reverts to box checking, & we're not ready to drop thinking from medicine #EULAR2022 @RheumNow https://t.co/ApBS4T4Wpc

CAR-T cell treatment of refractory systemic #lupus Biological results #SLE #EULAR2022 >CR https://t.co/JK4lsWcn2c

Remission in PsA ❗️According to DAS28-CRP *22% never achieve a state of remission *< than half achieved at least stage of SR ❗️According to DAPSA28 *73% never achieve a state of remission Are we that bad? Or do we need different measures? Or both? @RheumNow OP0262 #EULAR2022 https://t.co/6aeNW17VWg

📈 Machine learning driven phenotyping in PsA 4 clusters of pts treated w/ Guselkumab identified 📊 1 cluster w/ higher BL disease burden associated w/ worst response As fancy as it gets, not sure how to implement these in practice 🧐 @RheumNow #EULAR2022 OP0259 https://t.co/75X4ZqeEQJ